The journal has a clinical foundation and has been utilized most by clinical neurologists for improving the practice of neurology. While the focus is on neurology in India, the journal publishes manuscripts of high value from all parts of the world. Journal publishes reviews of various types, original articles, short communications, interesting images and case reports. The journal respects the scientific submission of its authors and believes in following an expeditious double-blind peer review process and endeavors to complete the review process within scheduled time frame. A significant effort from the author and the journal perhaps enables to strike an equilibrium to meet the professional expectations of the peers in the world of scientific publication. AIAN believes in safeguarding the privacy rights of human subjects. In order to comply with it, the journal instructs all authors when uploading the manuscript to also add the ethical clearance (human/animals)/ informed consent of subject in the manuscript. This applies to the study/case report that involves animal/human subjects/human specimens e.g. extracted tooth part/soft tissue for biopsy/in vitro analysis.

该期刊具有临床基础，临床神经病学家最常利用该期刊来改善神经病学实践。虽然该期刊的重点是印度的神经病学，但它也发表来自世界各地的高价值手稿。期刊发表各种类型的评论、原创文章、简短通讯、有趣的图像和病例报告。该期刊尊重作者的科学提交，并相信遵循快速的双盲同行评审流程，并努力在规定的时间内完成评审流程。作者和期刊的重大努力或许能够达到平衡，以满足科学出版界同行的专业期望。AIAN 相信维护人类受试者的隐私权。为了遵守这一规定，该期刊指示所有作者在上传手稿时也要在手稿中添加伦理许可（人类/动物）/受试者的知情同意。这适用于涉及动物/人类受试者/人类标本的研究/病例报告，例如提取的牙齿部分/用于活检/体外分析的软组织。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Nervous System Diseases领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为1.9，平均审稿速度为 29 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。